Stockholders of Bedford-based Hologic Inc. approved the company’s $6.2 billion purchase of Marlborough’s Cytyc Corp.
According to Hologic, more than 90 percent of shares represented at a meeting of stockholders this morning were voted in favor of the merger. The companies expect the deal to close next week. Under terms of the deal, Cytyc stockholders will receive slightly more than a half-share of Hologic common stock and $16.50 in cash for each share of Cytyc common stock they own.
Both companies are women’s health care diagnostic equipment and services developers.
